Her Premium Tripled. Nobody Called That a Relapse Trigger — But It Was One.

She had years of sobriety. She showed up to every appointment. Her drug screens were negative, she had her job back, she had her kids talking to her again. Then her insurance premium jumped from $40 a month to $138, and for the first time in years, her recovery was genuinely at risk — not because a craving hit her, but because a formulary letter did.

That’s the patient Dr. John Fomeche, an addiction medicine fellow at Yale, describes in a First Opinion piece this year. He doesn’t name her, and he shouldn’t. What he names instead is the thing nobody puts on a relapse-prevention worksheet: that a premium hike, a prior authorization delay, a plan that quietly drops your pharmacy is a clinical event, not paperwork, and it can undo years of work as fast as any trigger you were taught to watch for.

If you’re in recovery, you already know the version of vigilance you were trained for — watch the people, watch the places, watch the anniversaries. Nobody sits you down and says: watch the mail. Watch for the letter that says your plan changed. The psychology of that kind of threat is different from craving, and it’s worse in one specific way — you can’t out-cope it. You can build every skill your counselor ever taught you and still lose your medication access to a spreadsheet decision made by someone who has never met you.

The stakes here aren’t abstract. Research on Medicare beneficiaries with opioid use disorder found that even brief gaps in buprenorphine treatment measurably raise overdose risk — the kind of gap a lapsed prior authorization or a missed premium payment creates by default, with no malice and no warning. Fomeche’s argument is that insurance stability isn’t ancillary to treatment. It is treatment, in the same category as the medication itself, because interrupting either one restarts the same biological clock.

If a bill like that has ever landed in your mailbox mid-recovery, and your first feeling was closer to dread than annoyance — that reaction was correct. You weren’t overreacting to paperwork. You were correctly recognizing a threat to something you built, and that recognition is itself a form of the vigilance that’s kept you here this long. The fix isn’t more willpower. It’s calling your plan, your prescriber, or your pharmacy the day the letter arrives, not the week your refill is denied — and knowing that if you do lose the thread, that isn’t the story ending. It’s the system failing you in a way that has a name now, and a growing body of research behind it, instead of just a name for what it does to you.